COMMUNIQUÉS West-GlobeNewswire

KLAS ranks Imprivata OneSign as 2019 Single Sign-On Category Leader
06/02/2019
Customers rate Imprivata in 2019 in Best in KLAS: Software & Services Report LEXINGTON, Mass., Feb. 06, 2019 (GLOBE NEWSWIRE) -- Imprivata® , the healthcare IT security company, today announced that Imprivata [...]
Indiva Shapes Strong Brand Identity in Canada, Eyes Emerging European Market -- CFN Media
06/02/2019
SEATTLE, Feb. 06, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- CFN Media Group (“CFN Media”), the leading agency and financial media network dedicated to the North American cannabis industry, announces publication of an [...]
Marrone Bio Innovations’ almond bloom solutions increase farmer ROI and support new Almond Orchard 2025 Goals
06/02/2019
DAVIS, Calif., Feb. 06, 2019 (GLOBE NEWSWIRE) -- Marrone Bio Innovations Inc. (NASDAQ: MBII) (MBI), a leading developer of biological crop protection and plant health solutions, is offering a pair of products – Haven ® [...]
FSD Pharma Looks to Grow Cannabinoids in Algae -- CFN Media
06/02/2019
SEATTLE, Feb. 06, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- CFN Media Group (“CFN Media”), the leading agency and financial media network dedicated to the North American cannabis industry, announces publication of an [...]
resTORbio Appoints Erkan Baloglu, Ph.D., M.B.A., as Vice President of Drug Discovery and Medicinal Chemistry
06/02/2019
BOSTON, Feb. 06, 2019 (GLOBE NEWSWIRE) -- resTORbio, Inc. (Nasdaq:TORC), a clinical-stage biopharmaceutical company developing a new class of medicines that target the biology of aging to prevent or treat age-related [...]
Corvus Presents Updated Biomarker and Clinical Results from Lead Pipeline Programs CPI-444 and CPI-006 at Immuno-Oncology 360° Conference
06/02/2019
BURLINGAME, Calif., Feb. 06, 2019 (GLOBE NEWSWIRE) -- Corvus Pharmaceuticals, Inc. (Nasdaq: CRVS), a clinical-stage biopharmaceutical company focused on the development and commercialization of precisely targeted [...]
Eyenovia Announces FDA Acceptance of IND Application for MicroPine to Reduce the Progression of Myopia
06/02/2019
On track to initiate Phase III trial in H1 2019 NEW YORK, Feb. 06, 2019 (GLOBE NEWSWIRE) -- Eyenovia, Inc. (NASDAQ: EYEN), a clinical stage ophthalmic biopharmaceutical company developing a pipeline of microdose [...]
ChemioCare Reports Positive Animal Study Results for CMIO-Ondan Patch
06/02/2019
NEW YORK, Feb. 06, 2019 (GLOBE NEWSWIRE) -- ChemioCare USA Inc. (“ChemioCare” or the “Company”), a platform company based on proprietary transdermal delivery, today announced the minipig safety and pharmacokinetic study [...]
Stryker declares a $0.52 per share quarterly dividend
06/02/2019
Kalamazoo, Michigan, Feb. 06, 2019 (GLOBE NEWSWIRE) -- Stryker (NYSE:SYK) announced that its Board of Directors has declared a quarterly dividend of $0.52 per share payable on April 30, 2019 to shareholders of record at [...]
Bionano Genomics’ Saphyr® System Used for Highly Accurate Detection of the Genetic Disorder FSHD as an Alternative to Southern Blot
06/02/2019
Efforts to Validate Saphyr for Digital Cytogenetics are Accelerating SAN DIEGO, Feb. 06, 2019 (GLOBE NEWSWIRE) -- Bionano Genomics, Inc. (NASDAQ: BNGO), a life sciences instrumentation company that develops and markets [...]
Fibrocell to Present at 21st Annual BIO CEO & Investor Conference
06/02/2019
EXTON, Pa., Feb. 06, 2019 (GLOBE NEWSWIRE) -- Fibrocell Science, Inc. (NASDAQ: FCSC), a gene therapy company focused on transformational autologous cell-based therapies for skin and connective tissue diseases, today [...]
Zogenix Submits New Drug Application to U.S. Food & Drug Administration and Marketing Authorization Application to European Medicines Agency for FINTEPLA® for the Treatment of Dravet Syndrome
06/02/2019
EMERYVILLE, Calif., Feb. 06, 2019 (GLOBE NEWSWIRE) -- Zogenix, Inc. (NASDAQ:ZGNX), a global pharmaceutical company developing rare disease therapies, today announced it has completed its rolling submission of a New Drug [...]
Rexahn Announces Presentations at the 2019 ASCO Genitourinary Cancers Symposium
06/02/2019
ROCKVILLE, Md., Feb. 06, 2019 (GLOBE NEWSWIRE) -- Rexahn Pharmaceuticals, Inc. (NYSE American: RNN), a clinical stage biopharmaceutical company developing innovative therapies to improve patient outcomes in cancers that [...]
BioVie Completes Patient Enrollment for its Phase 2a Clinical Trial of BIV201 in Refractory Ascites
06/02/2019
LOS ANGELES, Feb. 06, 2019 (GLOBE NEWSWIRE) -- BioVie Inc. (OTCQB: BIVI) (“BioVie” or the “Company”), a clinical-stage company developing innovative drug therapies for liver disease, announced today that it has [...]
Dan Boren, Former Oklahoma Member of Congress, Joins SoldierStrong Advisory Board
06/02/2019
STAMFORD, Conn., Feb. 06, 2019 (GLOBE NEWSWIRE) -- Former Oklahoma congressman Dan Boren has joined the advisory board of SoldierStrong, a national nonprofit organization dedicated to improving the lives of the nation's [...]
Chimerix Announces Management Transition
06/02/2019
M. Michelle Berrey to Step Down as Chief Executive Officer DURHAM, N.C., Feb. 06, 2019 (GLOBE NEWSWIRE) -- Chimerix (NASDAQ:CMRX), a biopharmaceutical company developing novel antivirals to address life-threatening [...]
Catalyst Biosciences Announces Preclinical Proof-of-Concept Data of Gene Therapy Candidate CB 2679d-GT for the Treatment of Hemophilia B
06/02/2019
Results show a four-fold reduction in bleeding time for CB 2679d-GT and a three-fold improvement in clotting activity when compared with an AAV-encoding Padua vector Data presented at the 12 th Annual Congress of the [...]
ORYZON Announces Publication of a relevant paper for the therapeutic development of Iadademstat (ORY-1001) in Small Cell Lung Cancer (SCLC)
06/02/2019
Complete and durable tumor regression occurred with Iadademstat–induced NOTCH activation in a chemoresistant PDX model Further supports LSD1 inhibitors as a possible new and targeted therapy for SCLC Identifies the [...]
CareDx to Participate in BTIG 6th Annual Medical Technology, Life Science Tools and Diagnostics Conference
06/02/2019
BRISBANE, Calif., Feb. 06, 2019 (GLOBE NEWSWIRE) -- CareDx, Inc. (Nasdaq: CDNA), a molecular diagnostics company focused on the discovery, development and commercialization of clinically differentiated, high-value [...]

Pages